drugset / Trial / NCT00680667
Clinical Trial of Trametes Versicolor in Women With Breast Cancer
Phase 1
Completed
11 enrolled
Masonic Cancer Center, University of Minnesota
National Center for Complementary and Integrative Health (NCCIH) · collab
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Coriolus versicolor mushroom extract may slow the growth of cancer cells and may be an effective treatment for breast cancer. PURPOSE: This phase I trial is studying the side effects and best dose of coriolus versicolor extract in treating women with stage I, stage II, or stage III breast cancer who have finished radiation therapy.
Timeline
- Start
- 2007-04
- Primary completion
- 2011-04
- Completion
- 2011-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Trametes versicolor | Unknown | 3 g | Oral |
| Subject | Trametes versicolor | Unknown | 24 g | Oral |